ACDF postoperative pain management is a vital aspect of spine surgery. Therefore, surgeons must understand postoperative medication patterns. Initially, researchers studied over 4,000 patients from the nationwide FinSpine register. Specifically, they analyzed opioid and gabapentinoid purchases to assess recovery outcomes. Consequently, these findings offer a clear look at how patients transition away from analgesics after surgery.

Moreover, about 42% of patients used pain medications preoperatively. However, many stopped using these drugs after the procedure. Indeed, the cessation rate reached nearly 71% for both opioids and gabapentinoids. Because of this, ACDF remains an effective intervention for alleviating severe cervical pain. Nonetheless, a subset of patients continued their medication use. For instance, 16% of the cohort made repeated purchases during the first postoperative year. In addition, new strong-opioid use was rare. Specifically, only 2.2% of previously naïve patients started these drugs. Thus, the risk of new-onset strong opioid dependence remains low.

Predicting Success in ACDF postoperative pain management

Similarly, identifying risk factors helps in proactive clinical planning. For example, researchers identified preoperative pain duration of over one year as a major risk. Also, smoking and high baseline Neck Disability Index (NDI) scores correlate with prolonged use. Additionally, central canal stenosis and adverse working status play a significant role. Because of these factors, some patients struggle more during their recovery phase. Therefore, personalized follow-up and counseling are necessary for high-risk individuals. In conclusion, register data provides objective results for evaluating surgical outcomes. Finally, these findings assist clinicians in optimizing recovery and improving long-term patient satisfaction.

Frequently Asked Questions

What is the cessation rate for opioids after ACDF surgery?

According to the FinSpine study, approximately 69.5% of preoperative opioid users successfully discontinued the medication within the first year after surgery.

What are the primary risk factors for prolonged pain medication use?

Independent predictors include smoking, a preoperative pain duration exceeding one year, high baseline disability scores, and central canal stenosis.

How common is it for patients to start strong opioids for the first time after ACDF?

New initiation of strong opioids is uncommon. The study found that only 2.2% of patients who were previously opioid-naïve required repeated strong-opioid purchases postoperatively.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Klimko N et al. Opioid and Neuropathic Pain Medication use After ACDF for Degenerative Cervical Spine Disease - Nationwide FinSpine Register Study. Spine (Phila Pa 1976). 2026 Apr 09. doi: 10.1097/BRS.0000000000005705. PMID: 41954970.

Bakhsheshian J et al. Risk Factors for Prolonged Opioid Use After Spine Surgery. Journal of Neurosurgery: Spine. 2021.

Abtahi AM et al. Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery. ClinicalTrials.gov. 2023.